Sign in
Taking people in United StatesNo phase

Blood tests to find signs of active cardiac sarcoidosis

Studies blood exosomes for markers of disease activity in people with cardiac sarcoidosis.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
Status
Recruiting
People taking part
115 people, planned
Started
13 Jul 2026
Expected to end
Jul 2028
Type of study
Observational
Treatments tested
  • Exosome Analysis
Record updated
17 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults sent to the Cardiac Sarcoid Clinic because cardiac sarcoidosis (an inflammatory disease of the heart) is suspected or already confirmed. Blood samples will be studied to find markers of disease activity.

Age
18 years and older
Sex
All sexes
Disease stage
Suspected or previously confirmed cardiac sarcoidosis, active or inactive
Biomarker or test result
People must be having an FDG-PET scan as part of their standard care.

Main reasons for not taking part

  • Not able to give informed consent

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adults ≥18 years
  • Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis
  • Undergoing FDG-PET as part of standard care
  • Ability to provide informed consent

Who cannot take part

  • Inability to provide informed consent

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesContact: Anna PickTaking people

About the trial

What the trial wants to find out

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

The group in the trial

  • Cardiac Sarcoidosis Patients

    Patients with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.

    Treatment: Exosome Analysis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
Plain-language title
Blood tests to find signs of active cardiac sarcoidosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 August 2026